How Technology Companies Can Leverage the FDA’s Draft Guidance on AI-Enabled Devices
The Food and Drug Administration (FDA) recently released draft guidance on artificial intelligence (AI)-enabled medical devices, signaling an increase in regulatory oversight in this evolving field. Dr. Scott Schell, the chief medical officer at IT consulting firm Cognizant, emphasized that although the guidance is non-binding, it represents a pivotal shift…